Research Article
Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention
Table 1
Patient characteristics comparing nonadherent patients, patients with good adherence, and patients with full adherence (
).
| | Nonadherence
% | Good adherence
| Full adherence
% | value |
| | Patients, (%) | 66 (32%) | 58 (29%) | 78 (39%) | | | Male, (%) | 28 (33%) | 28 (35%) | 30 (32%) | | | Female, (%) | 38 (33%) | 30 (26%) | 48 (41%) | 0.519 | | Mean age (y, SD) | 76.8 (7.48) | 76.0 (10.31) | 76.0 (9.04) | 0.201 | | First stroke, (%) | 41 (27%) | 46 (30%) | 66 (43%) | 0.005 | | Recurrent stroke, (%) | 25 (51%) | 12 (25%) | 12 (24%) | | | Mean CHA2DS2-VASc | 5.87 (1.51) | 5.46 (1.60) | 5.51 (1.53) | 0.248 | | Mean HAS-BLED | 2.41 (0.72) | 2.48 (0.80) | 2.28 (0.79) | 0.306 | | Mean eGFR (SD) | 67.4 (19.5) | 67.9 (22.1) | 68.4 (18.1) | 0.951 | | NIHSS at discharge median (IQR) | 2 (1-4.5) | 2 (1-4) | 2 (0-5) | 0.965 | | Rivaroxaban, (%) | 21 (34%) | 22 (35%) | 19 (31%) | 0.247 | | Apixaban, (%) | 25 (30%) | 19 (23%) | 39 (47%) | | | Dabigatran, (%) | 10 (34%) | 10 (34%) | 9 (31%) | | | Warfarin, (%) | 10 (36%) | 7 (25%) | 11 (39%) | |
|
|
MPR: medication possession ratio; SD: standard deviation; IQR: interquartile range; eGFR: estimated glomerular filtration rate; NIHSS: National Institutes of Health Stroke Scale.
|
